Davis, CA, United States of America

Jiro Kusunose


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 48(Granted Patents)


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jiro Kusunose: Innovator in Targeted Therapeutics

Introduction

Jiro Kusunose is a prominent inventor based in Davis, CA (US). He has made significant contributions to the field of targeted therapeutics, particularly through his innovative approaches to peptide technology. His work focuses on enhancing the selectivity of therapeutic agents for specific tissues, which has important implications for medical treatments.

Latest Patents

Kusunose holds a patent titled "Methods and compounds for targeting tissues." This invention relates to peptides that home to cells, such as heart cells, with high selectivity. These peptides can be utilized in compositions that selectively target a systemically administered therapeutic agent or imaging agent to specific cells or tissues in a subject. The patent also outlines methods for using these compositions in imaging, such as PET imaging, and for delivering therapeutic agents to target cells.

Career Highlights

Jiro Kusunose is affiliated with the University of California, where he continues to advance research in targeted therapies. His work has garnered attention for its potential to improve treatment outcomes in various medical conditions by ensuring that therapeutic agents reach their intended targets effectively.

Collaborations

Kusunose has collaborated with notable colleagues, including Katherine W. Ferrara and Hua Zhang. These partnerships have contributed to the development of innovative solutions in the field of targeted therapeutics.

Conclusion

Jiro Kusunose's contributions to the field of targeted therapeutics through his patented inventions highlight the importance of innovation in medicine. His work exemplifies how advancements in peptide technology can lead to more effective treatments for patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…